Dr. Mojtaba S. Olyaee, M.D.
Gastroenterology (Gastroenterology Physician)
3901 Rainbow Blvd, Rm 4035, Wescoe Mailstop 1023
Kansas City,, KS 66160
- Medicare participating
At a glance
- Years since graduation
- 42
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 612
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
KS license 04-25364
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Kansas Hospital Kansas City, KS
- University of Kansas Health System Olathe Hospital Olathe, KS
- Stormont Vail Hospital Topeka, KS
- Mosaic Life Care at St Joseph Saint Joseph, MO
- Hedrick Medical Center Chillicothe, MO
Medical groups
- Kansas University Physicians Inc (1,849 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 612
- Services billed
- 1,476
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 191 | 182 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 187 | 132 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 156 | 99 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 137 | 98 |
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 93 | 90 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 90 | 89 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 84 | 72 |
| Replacement of stent in pancreatic or bile duct using a flexible endoscope | 80 | 44 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 74 | 68 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 63 | 63 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tacrolimus Other prescribers in Kansas City,, KS | 293 |
| Ursodiol Other prescribers in Kansas City,, KS | 96 |
| Peg 3350-Electrolyte (sodium chloride/nahco3/kcl/peg) | 94 |
| Spironolactone Other prescribers in Kansas City,, KS | 89 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Kansas City,, KS | 84 |
| Xifaxan (rifaximin) Other prescribers in Kansas City,, KS | 74 |
| Furosemide Other prescribers in Kansas City,, KS | 69 |
| Omeprazole Other prescribers in Kansas City,, KS | 63 |
| Carvedilol Other prescribers in Kansas City,, KS | 61 |
| Azathioprine Other prescribers in Kansas City,, KS | 51 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 8 payments worth $764 in total to this clinician.
| Cook Medical LLC | $540 |
|---|---|
| Boston Scientific Corporation | $177 |
| Qol Medical, LLC | $47.41 |
| Food and Beverage | $764 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 1 companies. The companies reported $14,205 in research payments for these studies, mostly to the institutions running them.
- A phase 4 study evaluating real-world use of cdpath?, a crohn's disease risk prediction tool
Takeda Pharmaceuticals U.S.A., Inc. - Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula
Takeda Pharmaceuticals U.S.A., Inc. · Completed · NCT04075825 - Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)
Takeda Pharmaceuticals U.S.A., Inc. · Completed · NCT03279081
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.